MedPath

The Usability, Acceptability, and Perceived Value of the Cornerstones4Care Powered by Glooko App

Not Applicable
Conditions
Diabetes Mellitus, Type 2
Interventions
Device: Cornerstones4Care Powered by Glooko App
Registration Number
NCT03222284
Lead Sponsor
Healthcare Innovation Technology Lab
Brief Summary

This is a two-armed mixed methods study of participants (n=30) diagnosed with type 2 diabetes who use a blood glucose meter as part of their treatment regimen. Participants will have either two or three visits at HITLAB during the 28-day study period.

Detailed Description

The purpose of this study is to evaluate the utility and user experience of a mobile application, called Cornerstones4Care Powered by Glooko App (C4C), for persons diagnosed with diabetes type 2.Subjects will be asked to use the Cornerstones4Care Powered by Glooko App for an approximately 20 minute monitored demonstration session, followed by a 28-day period of daily engagement with the application.The Cornerstones4Care Powered by Glooko App lets users input nutrition, medication, exercise and other daily information to assist in the management of diabetes type 2. It also has the ability to sync with connected devices, such as blood glucose monitors. Additionally, the application offers a library of educational content for users.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Be diagnosed with type 2 diabetes
  2. Live in the New York Metropolitan area
  3. Be at least 18 years of age
  4. Able to read, write, and speak in English
  5. Have an iPhone or Android phone
  6. Use a blood glucose meter
  7. Regularly take insulin by injection
  8. Be willing to follow study requirements for a 28-day period
Exclusion Criteria
  1. Not be diagnosed with type 2 diabetes
  2. Not living in the New York Metropolitan area
  3. Be less than 18 years of age
  4. Be unable to read, write, and speak in English
  5. Not have an iPhone or Android phone
  6. Not use a blood glucose meter
  7. Not regularly take insulin by injection
  8. Be unwilling to follow study requirements for a 28-day period

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 2Cornerstones4Care Powered by Glooko AppN=20 Device intervention 1. Cornerstones4Care Powered by Glooko App Visits Day 1 Day 28
Group 1Cornerstones4Care Powered by Glooko AppN=10 Device intervention 1. Cornerstones4Care Powered by Glooko App Visits Day 1 Day 7 Day 28
Primary Outcome Measures
NameTimeMethod
Device usability as assessed by the System Usability Scale (SUS)28 days
Usage of the Cornerstones4Care Powered by Glooko App as assessed by self-report28 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Healthcare Innovation and Technology Lab

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath